Category: Clinical Breakthroughs
-
Pharmacogenomics for All
Northwestern Medicine investigators are on a mission to bring precision medicine to African-Americans.
-
Trial Shows Drug Rapidly Reverses Blood Thinner’s Effects
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
-
Online Tool Predicts Heart Disease Events in Young Adults
An online calculator showed initial success at predicting the risk of heart disease events among young, healthy adults, according to a new study in JAMA Internal Medicine.
-
Surgical Residents Adapting to Flexible Shift Hours
Karl Bilimoria, MD, MS, associate professor of Surgery, found growing acceptance of new flexible shift lengths in a national survey of surgical residents.
-
Assessing the Accuracy of Cardiovascular Data in Electronic Health Records
Northwestern Medicine investigators identified key areas of agreement and disagreement between cardiovascular data collected from electronic health records and data gathered in a traditional cohort study.
-
Precision Medicine for “All of Us”
Northwestern will play a key role in “All of Us,” a groundbreaking national research effort to gather data from one million or more people in order to advance precision medicine.
-
Reversing Fetal Alcohol Damage After Birth
Two commonly used drugs erased the learning and memory deficits caused by fetal alcohol exposure when the drugs were given after birth, according to a new study.
-
Investigating Relevance of Internal Medicine Recertification Exam
Almost 70 percent of questions on the American Board of Internal Medicine’s Maintenance of Certification exam concurred with the frequency of conditions seen in general internal medicine practice, according to a JAMA study.
-
Investigating the Survival Benefit of Aggressive Procedure for Melanoma
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
-
Investigating the Financial Burden of Cancer Drugs on Medicare Patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare’s prescription drug benefit program, Part D, according to a new study.
